41 results
8-K
EX-99.1
BFRI
Biofrontera Inc
15 Mar 24
Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update
5:20pm
, net
Operating expenses
Cost of revenues, related party
Cost of revenues, other
Selling, general and administrative, related party
Research … and development
Change in fair value of contingent consideration
Total operating expenses
Loss from operations
Other income (expense)
Change in fair value
8-K
EX-10.1
BFRI
Biofrontera Inc
23 Feb 24
Biofrontera Inc. Announces Closing of Private Placement of Up To $16.0 Million priced at market per Nasdaq rules
9:26am
, manufacturing and production processes and techniques, research and development information, drawings, specifications, designs, plans, proposals, non
8-K
EX-10.1
2dczj xeg5z6mh
20 Feb 24
Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG
9:37am
8-K
EX-99.1
swwv e81mb
9 Nov 23
Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update
5:15pm
424B4
fiigu9a4u7y
1 Nov 23
Prospectus supplement with pricing info
5:09pm
8-K
EX-99.1
lrwjjq 2r
3 Oct 23
Other Events
5:17pm
8-K
EX-99.1
sttpdlh33q o8zqaeo
11 Aug 23
Biofrontera Inc. Reports Second Quarter 2023 Financial Results and Provides a Business Update
7:30am
8-K
EX-99.1
uzd3r5rr6ta hxn
30 May 23
Biofrontera Inc. Names Founder and Executive Chairman Hermann
9:00am
424B3
eii rwne2tym389gr
8 Apr 22
Prospectus supplement
9:47pm
424B3
pk9zyeg1 p6nej5q
8 Apr 22
Prospectus supplement
9:45pm